Skip to content

A CLINICAL STUDY ON HOMOEOPATHIC TREATMENT IN PATIENTS WITH ALLERGIC RHINITIS

A CLINICAL STUDY TO ESTIMATE THE VARIATION IN IGE LEVELS IN PATIENTS WITH ALLERGIC RHINITIS BEFORE AND AFTER CONSTITUTIONAL HOMEOPATHIC MEDICINES

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038452
Enrollment
50
Registered
2021-12-06
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: CONSTITUTIONAL HOMEOPATHIC MEDICINE: CONSTITUTIONAL HOMEOPATHIC MEDICINE - selected based on the totality of individual patient symptoms, dose - as per instructions in organon of medici

Sponsors

DrManoj Narayan self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Confirmed diagnosis of persistent allergic rhinitis. Both sexes aged between 5 and 50 years.

Exclusion criteria

Exclusion criteria: Homeopathy combined with another intervention. Presence of upper respiratory infections in the last month. Presence of obstructive lung infections Chronic respiratory diseases Cardiovascular disease Known chronic infections Mental illness Known malignancy Inflammatory connective tissue

Design outcomes

Primary

MeasureTime frame
The total Quality of Life Score; individual symptoms scores which includes any appropriate measures of nasal obstruction, runny nose, sneezing, itching, and eye symptoms. In case of child participants, AR symptoms rated by parents will be considered acceptable. Timepoint: end of 3rd and 6th month total Quality of Life Score; end of 3rd and 6th month individual symptoms scores which includes any appropriate measures of nasal obstruction, runny nose, sneezing, itching, and eye symptoms. In case of child participants, AR symptoms rated by parents will be considered acceptable.

Secondary

MeasureTime frame
Individual ocular symptoms, any adverse event, hospitalization due to an adverse event, and use of conventional medication (frequency and quantity).Timepoint: During the whole study period

Countries

India

Contacts

Public ContactDrMMurugan

Sarada Krishna Homoeopathic Medical College

drmmuruganhomoeo@gmail.com9443343707

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026